Articles From: Oclaro to Announce Second Quarter Fiscal Year 2015 Financial Results on Tuesday, February 3, 2015 to Ofcom Rejects Virgin Media's Call to Pause Premier League Auction


2015/1/20
SAN JOSE, Calif.
Sign-up for Oclaro to Announce Second Quarter Fiscal Year 2015 Financial Results on Tuesday, February 3, 2015 investment picks
2015/1/5
SAN JOSE, Calif.
Sign-up for Oclaro to Present at the Needham Annual Growth Conference investment picks
2015/1/21
Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, announced today enrollment of the first patient in a Phase 2 clinical trial to evaluate the safety and efficacy of Sustained Release Dexamethasone (OTX-DP), an ophthalmic corticosteroid for the treatment of inflammatory dry eye disease.
Sign-up for Ocular Therapeutix™ Enrolls First Patient in Phase 2 Clinical Trial for Sustained Release Dexamethasone for the Treatment of Dry Eye Disease investment picks
2015/2/19
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will participate in two upcoming conferences: A live audio webcast of the presentations can be accessed through the Calendar of Events section of the Company's website at investors.ocutx.com .
Sign-up for Ocular Therapeutix™ to Participate in Two Upcoming Investor Conferences investment picks
2014/12/2
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will present a corporate overview at the Oppenheimer 25th Annual Healthcare Conference on Thursday, December 11, 2014 at 3:20 p.m. Eastern Time at the Crowne Plaza Hotel in New York City.
Sign-up for Ocular Therapeutix™ to Present at Oppenheimer 25th Annual Healthcare Conference investment picks
2015/2/4
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Brad Smith, Chief Financial Officer, will present a corporate overview at the 17th Annual BIO CEO & Investor Conference on Monday, February 9, 2015 at 4:30 p.m. Eastern Time at the Waldorf Astoria in New York City.
Sign-up for Ocular Therapeutix™ to Present at the 17th Annual BIO CEO & Investor Conference investment picks
2015/1/29
PETALUMA, Calif., Jan.
Sign-up for Oculus Innovative Sciences Announces Fiscal Third Quarter 2015 Financial Results and Conference Call investment picks
2015/1/7
Multiple Microcyn®-Based Dermatology Products for Management of Pain/Itch and Scar Management Now Commercialized in the United States Four New Dermatology Products for Management of Scars, Atopic Dermatitis and Mild-to-Moderate Acne Now Commercialized in Europe PETALUMA, Calif., Jan.
Sign-up for Oculus Innovative Sciences Announces New Dermatology Division, IntraDerm Pharmaceuticals investment picks
2015/1/12
PETALUMA, Calif., Jan.
Sign-up for Oculus Innovative Sciences Enters Into Agreement to Sell Ruthigen, Inc. Shares for $5.5 Million in Event of Ruthigen Merger investment picks
2015/2/12
Total revenue of $3.2 million for the third quarter Oculus has agreed to sell its two million shares of common stock held in Ruthigen, Inc. (Nasdaq:RTGN) for $5.5 million if a Ruthigen merger transaction occurs Oculus added $5.3 million to its cash position on January 26, 2015, from the sale of common shares and warrants, net of offering costs Conference Call Begins at 4:30 p.m. (ET) Today PETALUMA, Calif., Feb.
Sign-up for Oculus Innovative Sciences Reports Financial Results for the Third Quarter of Fiscal Year 2015 investment picks
2014/12/12
ATLANTA, Dec.
Sign-up for Ocwen Announces $253 Million Early Buyout of Mortgages From Ginnie Mae Pools investment picks
2015/1/21
ATLANTA, Jan.
Sign-up for Ocwen Appoints Two New Independent Directors investment picks
2015/2/18
ATLANTA, Feb.
Sign-up for Ocwen Comments on HLSS Announced Agreement With HSART Trust investment picks
2014/12/16
ATLANTA, Dec.
Sign-up for Ocwen Comments on National Mortgage Settlement Monitor's Report investment picks
2015/1/13
Anticipates Resolution Through Cooperation With Prescribed Administrative Process ATLANTA, Jan.
Sign-up for Ocwen Cooperating With California Dept. of Business Oversight investment picks
2014/12/22
ATLANTA, Dec.
Sign-up for Ocwen Financial Agrees to Settlement With New York Dept. of Financial Services investment picks
2015/1/26
Ocwen Financial Corp.'s stock (OCN) was surging about 20% in morning trade Monday, after the company agreed to pay $2.5 million in a settlement with California's Department of Business Oversight, according to an announcement late Friday.
Sign-up for Ocwen Financial Corp.'s stock surges 20% after settlement investment picks
2015/1/26
ATLANTA, Jan.
Sign-up for Ocwen Financial Corporation Responds to BlueMountain Letter investment picks
2015/2/23
ATLANTA, Feb.
Sign-up for Ocwen Financial Intends to Sell $9.8 Billion Portfolio of Mortgage Servicing Rights to Nationstar investment picks
2015/1/13
Ocwen Financial Corp.
Sign-up for Ocwen Financial may lose mortgage license in California investment picks
2015/1/13
By James Sterngold California seeks to suspend firm's business license in state Shares of beleaguered mortgage-servicing firm Ocwen Financial Corp.
Sign-up for Ocwen Financial's shares tumble on California concerns investment picks
2014/12/22
Shares of Ocwen Financial (OCN) tumbled 13% in early trade Monday, after the mortgage services company said in a regulatory filing that it will pay a $100 million civil monetary penalty to the New York Department of Financial Services to settle allegations of improper conduct.
Sign-up for Ocwen Financial's stock tumbles after announcing settlement with NY DFS investment picks
2015/2/10
ATLANTA, Feb.
Sign-up for Ocwen Hosts Second Community Advisory Council Meeting investment picks
2015/1/26
An attorney for Ocwen Financial Corp., the embattled mortgage-servicing company, on Monday issued a letter rejecting efforts by a group of large investors seeking to remove the firm as servicer of $82 billion of residential mortgage-backed securities.
Sign-up for Ocwen Rejects 'Baseless Allegations' of Mortgage Investors investment picks
2015/1/26
By James Sterngold Ocwen Financial Corp., the embattled mortgage-servicing company, on Monday rejected efforts by a group of large investors to remove the firm as servicer of billions of dollars of residential mortgage-backed securities.
Sign-up for Ocwen Rejects 'Baseless Allegations' of Mortgage Investors -- Update investment picks
2015/1/26
ATLANTA, Jan.
Sign-up for Ocwen Responds to Gibbs & Bruns in Regards to RMBS Investors investment picks
2015/1/13
Ocwen Financial Corp.
Sign-up for Ocwen says cooperating with California, expects to resolve action investment picks
2015/1/23
Shares of Ocwen Financial Corp.
Sign-up for Ocwen sinks amid claims of affiliate default investment picks
2015/2/6
By Rory Gallivan LONDON--U.K. communications regulator Ofcom said Friday it plans to impose new controls on the amount mobile telecommunications companies can charge when their customers receive calls from people using different networks.
Sign-up for Ofcom Plans New Controls on Charges for Calls Between Mobile Networks investment picks
2015/2/4
By Ed Ballard LONDON--The U.K.'s media regulator has rejected an application from Virgin Media, Liberty Global PLC's (LBTYA) British cable operator, to pause an auction for the live broadcast rights to English Premier League soccer games.
Sign-up for Ofcom Rejects Virgin Media's Call to Pause Premier League Auction investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Oclaro to Announce Second Quarter Fiscal Year 2015 Financial Results on Tuesday, February 3, 2015 to Ofcom Rejects Virgin Media's Call to Pause Premier League Auction
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent